Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1996 Mar;117(6):1089–1094. doi: 10.1111/j.1476-5381.1996.tb16701.x

Increase by adrenaline or angiotensin II of the accumulation of low density lipoprotein and fibrinogen by aortic walls in unrestrained conscious rats.

L E Cardona-Sanclemente 1, G V Born 1
PMCID: PMC1909768  PMID: 8882601

Abstract

1. Earlier experiments of ours with anaesthetized rabbits showed that infusions of catecholamines into the carotoid blood stream significantly increased the uptake of radioiodinated low density lipoprotein (LDL) by the artery wall after as little as 2 h. This observation has now been extended to much longer time periods, i.e., 6 days, and another species, viz. conscious and unrestrained rats; also to another pressor agent, angiotensin II, as well as to another plasma protein, fibrinogen. 2. Groups of rats were infused from subcutaneously implanted osmotic minipumps for 6 days. The infusions were either into a carotid artery or into the surrounding tissues, with essentially the same effects. Control animals were infused with saline, and test animals with either adrenaline or angiotensin II. The minipump concentration of adrenaline of 4-5 microM, which gave blood concentrations of 25-41 nM, increased the blood pressure significantly after 3 days. The minipump concentration of angiotensin II of 9.9 mg ml-1 was chosen to produce similar increases in blood pressure. 3. Five days after starting the infusion, rats were injected i.v. with either homologous or human LDL labelled with [125I]-tyramine cellobiose (TC), or with [131I]-TC labelled human fibrinogen. Twenty-four hours later, the animals were killed and the radioactivities determined in the whole aorta. The labelled TC radioactivities represent primarily metabolised protein (because TC is trapped intracellularly), but also include the fraction of intact, i.e., non-metabolized protein in transit through the vessel wall. To determine the contribution of the latter, in some experiments we injected double-labelled [131I]-[125TC]-LDL only. These experiments showed that the [131I]-LDL counts representing protein in transit accounted for approx. 20% of the total 125TC counts, and that this percentage was not significantly affected by adrenaline or angiotensin II. Therefore, the bulk of the experiments was carried out with single labelled proteins, using 125I to label TC-LDL and 131I to label TC-fibrinogen. In these experiments, the radioactivity of the arterial wall thus provides a cumulative measure of the uptake and degradation of proteins. 4. Aortic wall radioactivities from rat and human LDL and from human fibrinogen were significantly increased by both agents. Adrenaline at 25-41 nM increased the radioactivities by 52 and 47% for rat and human LDL respectively, and by 31% for human fibrinogen; these differences were highly significant (P < 0.01). Angiotensin II at ca. 10 nM also increased the radioactivities significantly, by 21% for human LDL and by 109% for human fibrinogen (P < 0.05). 5. The results suggest that the accumulation of LDL and of fibrinogen by rat aorta is increased by adrenaline or by angiotensin II at concentrations which raise the blood pressure progressively and significantly after 3 or 5 days respectively.

Full text

PDF
1089

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baldwin A., Lever M. J., Caro C. G. Effect of noradrenaline, sodium nitrite and isosorbide dinitrate on albumin transport in the wall of the excised rabbit common carotid artery. Atherosclerosis. 1983 Jan;46(1):1–11. doi: 10.1016/0021-9150(83)90158-2. [DOI] [PubMed] [Google Scholar]
  2. Brown M. J., Jenner D. A. Novel double-isotope technique for enzymatic assay of catecholamines, permitting high precision, sensitivity and plasma sample capacity. Clin Sci (Lond) 1981 Nov;61(5):591–598. doi: 10.1042/cs0610591. [DOI] [PubMed] [Google Scholar]
  3. Brown M. S., Goldstein J. L. A receptor-mediated pathway for cholesterol homeostasis. Science. 1986 Apr 4;232(4746):34–47. doi: 10.1126/science.3513311. [DOI] [PubMed] [Google Scholar]
  4. Buelke-Sam J., Holson J. F., Bazare J. J., Young J. F. Comparative stability of physiological parameters during sustained anesthesia in rats. Lab Anim Sci. 1978 Apr;28(2):157–162. [PubMed] [Google Scholar]
  5. Cardona-Sanclemente L. E., Born G. V. Adrenaline increases the uptake of low-density lipoproteins in carotid arteries of rabbits. Atherosclerosis. 1992 Oct;96(2-3):215–218. doi: 10.1016/0021-9150(92)90067-q. [DOI] [PubMed] [Google Scholar]
  6. Cardona-Sanclemente L. E., Born G. V. Effect of inhibition of nitric oxide synthesis on the uptake of LDL and fibrinogen by arterial walls and other organs of the rat. Br J Pharmacol. 1995 Apr;114(7):1490–1494. doi: 10.1111/j.1476-5381.1995.tb13375.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cardona-Sanclemente L. E., Ferezou J., Lutton C. Cholesterol metabolism in the genetically hypercholesterolemic (RICO) rat. II. A study of plasma lipoproteins and effect of dietary cholesterol. Biochim Biophys Acta. 1988 Jun 15;960(3):382–389. doi: 10.1016/0005-2760(88)90046-x. [DOI] [PubMed] [Google Scholar]
  8. Cardona-Sanclemente L. E., Medina R., Born G. V. Effect of increasing doses of angiotensin II infused into normal and hypertensive Wistar rats on low density lipoprotein and fibrinogen uptake by aortic walls. Proc Natl Acad Sci U S A. 1994 Apr 12;91(8):3285–3288. doi: 10.1073/pnas.91.8.3285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Collins R., Peto R., MacMahon S., Hebert P., Fiebach N. H., Eberlein K. A., Godwin J., Qizilbash N., Taylor J. O., Hennekens C. H. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet. 1990 Apr 7;335(8693):827–838. doi: 10.1016/0140-6736(90)90944-z. [DOI] [PubMed] [Google Scholar]
  10. DUNCAN L. E., Jr, CORNFIELD J., BUCK K. The effect of blood pressure on the passage of labeled plasma albumin into canine aortic wall. J Clin Invest. 1962 Jul;41:1537–1545. doi: 10.1172/JCI104610. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Feig L. A., Peppas N. A., Colton C. K., Smith K. A., Lees R. S. The effect of angiotensin II on in vivo albumin transport in normal rabbit aortic tissue. Atherosclerosis. 1982 Sep;44(3):307–318. doi: 10.1016/0021-9150(82)90005-3. [DOI] [PubMed] [Google Scholar]
  12. Fidge N. H., Poulis P. Metabolic heterogeneity in the formation of low density lipoprotein from very low density lipoprotein in the rat: evidence for the independent production of a low density lipoprotein subfraction. J Lipid Res. 1978 Mar;19(3):342–349. [PubMed] [Google Scholar]
  13. Goldstein J. L., Brown M. S. The low-density lipoprotein pathway and its relation to atherosclerosis. Annu Rev Biochem. 1977;46:897–930. doi: 10.1146/annurev.bi.46.070177.004341. [DOI] [PubMed] [Google Scholar]
  14. HAVEL R. J., EDER H. A., BRAGDON J. H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 1955 Sep;34(9):1345–1353. doi: 10.1172/JCI103182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Koga S., Horwitz D. L., Scanu A. M. Isolation and properties of lipoproteins from normal rat serum. J Lipid Res. 1969 Sep;10(5):577–588. [PubMed] [Google Scholar]
  16. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  17. Nagelkerke J. F., Havekes L., van Hinsbergh V. W., van Berkel T. J. In vivo and in vitro catabolism of native and biologically modified LDL. FEBS Lett. 1984 Jun 4;171(1):149–153. doi: 10.1016/0014-5793(84)80477-9. [DOI] [PubMed] [Google Scholar]
  18. Parker J. L., Adams H. R. The influence of chemical restraining agents on cardiovascular function: a review. Lab Anim Sci. 1978 Oct;28(5):575–583. [PubMed] [Google Scholar]
  19. Pittman R. C., Carew T. E., Glass C. K., Green S. R., Taylor C. A., Jr, Attie A. D. A radioiodinated, intracellularly trapped ligand for determining the sites of plasma protein degradation in vivo. Biochem J. 1983 Jun 15;212(3):791–800. doi: 10.1042/bj2120791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Shafi S., Cusack N. J., Born G. V. Increased uptake of methylated low-density lipoprotein induced by noradrenaline in carotid arteries of anaesthetized rabbits. Proc R Soc Lond B Biol Sci. 1989 Jan 23;235(1281):289–298. doi: 10.1098/rspb.1989.0001. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES